NSIS-B:CPH
Novozymes A/S
DKK 367.10
arrow_upward
+0.22%(+0.80) 1D
Jun 4, 5:00:00 PM GMT+2 · DKK
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NSIS-B...
Open
DKK 367.00
High
DKK 370.00
Low
DKK 365.30
Mkt. cap
152.19B
Avg. vol.
677.30K
Volume
439.80K
52-wk high
DKK 489.40
52-wk low
DKK 336.80
Shares outstanding
414.56M
No. of employees
11K
Open
DKK 367.00
High
DKK 370.00
Low
DKK 365.30
Mkt. cap
152.19B
Avg. vol.
677.30K
Volume
439.80K
52-wk high
DKK 489.40
52-wk low
DKK 336.80
Shares outstanding
414.56M
No. of employees
11K
Analyst outlook
Analyst Ratings
Based on 8 analysts giving stock ratings to NSIS-B in the past 3 months
Strong Buy
Buy
8
Hold
0
Sell
0
12 month forecast
Based on 8 Wall Street analysts offering 12 month price targets for NSIS-B in the last 3 months.
Highest
Current €367.10
Average
€62.33 (-83.02%)
Lowest
€54.85 (-85.06%)
News stories
From sources across the web
Foreign Policy Journal
·
13 minutes ago
Quantum Computing Firm Quantinuum (NASDAQ: QNT) Raises $1.68bn In Heavily Oversubscribed IPO
AOL.com
·
21 minutes ago
$10,000 in VOLT Became $13,750 in Six Months While the S&P 500 Limped to $11,100
The Globe and Mail
·
15 minutes ago
Ribbon Acquisition Faces Nasdaq Delisting Over Unpaid Fees
Profile
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, outside of Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange. Wikipedia
About Novozymes A/S
AI content may include mistakes. Learn more